A GAME CHANGER ANTIVIRAL PILL CUTS COVID DEATHS BY 50% – HERE IS HOW TO INVEST
By Nigam Arora & Dr. Natasha Arora
Game Changer
Merck (MRK) has announced that its oral antiviral pill molnupiravir reduces the death risk from COVID by 50%. 7.3% of those who received the pill were either hospitalized or died through Day 29 compared with 14.1% of those who received the placebo. The data was so positive that the study was stopped early.
Merck plans to seek Emergency Use Authorization.
Technicals
The first resistance zone for MRK is $81.75 to $84. The second resistance zone is $86.47 to $88.41. The resistance is likely to slow the move up in a normal market. … Please click here or the title below to read more.
October 1, 2021